Comments on: ‘Anaphylaxis caused by in‐season switchover of sublingual immunotherapy formulation’

Publisher: John Wiley & Sons Inc

E-ISSN: 1399-3038|25|7|715-716

ISSN: 0905-6157

Source: PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.25, Iss.7, 2014-11, pp. : 715-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract